Stool transplant for C-section babies' health
Part of Hormones & metabolism clinical trials.
This trial tests whether giving a special stool transplant (fecal microbiota) to healthy babies born by C-section can improve their health. It aims to see if this treatment helps replace good bacteria that are normally passed during a vaginal birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pregnant woman between 18 and 49 years old
- Your C-section is planned (elective) and will be at 37 weeks or later
- You are not taking strong medications that affect your immune system, like certain biologics
- You are pregnant with only one baby
- Your newborn is healthy (born at term, over 5.5 pounds, and no need for intensive care, breathing help, or antibiotics right after birth)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This trial tests if a fecal microbiota transplant (FMT) can improve survival and recovery in ICU patients with sepsis. FMT involves transferring healthy donor bacteria into your gut to help fight severe infection.
This trial tests whether transplanting stool bacteria into the colon (fecal microbiota transplantation) can improve ulcerative colitis symptoms in people with active, moderate to severe disease. If you qualify, the study team will also check that it’s safe for you and that you can safely undergo a scope exam.
This trial tests whether giving a small dose of the mother's vaginal bacteria to babies born by C-section can help restore their gut microbiome. It may reduce the risk of allergies and other immune-related conditions later in life.
This trial tests whether a multi-strain probiotic supplement can help with growth, digestion, and gut health in healthy full-term babies who were born by C-section.
This trial studies whether transferring healthy stool bacteria into the gut (fecal microbiota transplantation, or FMT) can improve symptoms in children with ulcerative colitis. It may help by changing gut bacteria, especially for children who are newly diagnosed or who didn’t respond to standard treatments.
Hear when a new Fecal Microbiota Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.